| Insights into cancer metastasis from a clinicopathologic perspective: Epithelial‐Mesenchymal Transition is not a necessary step MH Chui International journal of cancer 132 (7), 1487-1495, 2013 | 138 | 2013 |
| The histomorphology of Lynch syndrome–associated ovarian carcinomas: toward a subtype-specific screening strategy MH Chui, P Ryan, J Radigan, SE Ferguson, A Pollett, M Aronson, ... The American journal of surgical pathology 38 (9), 1173-1181, 2014 | 125 | 2014 |
| Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy RC Wu, A Ayhan, D Maeda, KR Kim, BA Clarke, P Shaw, MH Chui, ... The Journal of pathology 232 (4), 473-481, 2014 | 109 | 2014 |
| Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy Y Park, MH Chui, Y Suryo Rahmanto, ZC Yu, RA Shamanna, MA Bellani, ... Clinical Cancer Research 25 (18), 5584-5594, 2019 | 92 | 2019 |
| In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas MK McConechy, LN Hoang, MH Chui, J Senz, W Yang, N Rozenberg, ... The Journal of Pathology: Clinical Research 1 (3), 173-185, 2015 | 87 | 2015 |
| Correlation of PD-L1 expression with tumor mutation burden and gene signatures for prognosis in early-stage squamous cell lung carcinoma H Yu, Z Chen, KV Ballman, MA Watson, R Govindan, I Lanc, DG Beer, ... Journal of Thoracic Oncology 14 (1), 25-36, 2019 | 84 | 2019 |
| Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in … MH Chui, CA Cassol, SL Asa, O Mete Virchows Archiv 462, 557-563, 2013 | 68 | 2013 |
| Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype MH Chui, CB Gilks, K Cooper, BA Clarke Advances in anatomic pathology 20 (6), 378-386, 2013 | 55 | 2013 |
| Histopathologic features of prognostic significance in high-grade osteosarcoma MH Chui, RA Kandel, M Wong, AM Griffin, RS Bell, ME Blackstein, ... Archives of pathology & laboratory medicine 140 (11), 1231-1242, 2016 | 53 | 2016 |
| Antioxidant vitamins reduce acute meal-induced memory deficits in adults with type 2 diabetes MH Chui, CE Greenwood Nutrition Research 28 (7), 423-429, 2008 | 42 | 2008 |
| Case report: Adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome MH Chui, NC Özbey, S Ezzat, Y Kapran, Y Erbil, SL Asa Endocrine Pathology 20 (4), 256, 2009 | 39 | 2009 |
| Clinicopathologic and molecular features of paired cases of metachronous ovarian serous borderline tumor and subsequent serous carcinoma MH Chui, D Xing, F Zeppernick, ZQ Wang, CG Hannibal, K Frederiksen, ... The American journal of surgical pathology 43 (11), 1462-1472, 2019 | 35 | 2019 |
| Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma TT Yen, T Miyamoto, S Asaka, MH Chui, Y Wang, SF Lin, RL Stone, ... Gynecologic oncology 150 (3), 426-431, 2018 | 35 | 2018 |
| MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma B Manning-Geist, S Gordhandas, YL Liu, Q Zhou, A Iasonos, ... Clinical Cancer Research 28 (20), 4456-4465, 2022 | 31 | 2022 |
| Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas DS Ross, KA Devereaux, C Jin, DYT Lin, Y Zhang, A Marra, V Makker, ... Modern Pathology 35 (7), 962-971, 2022 | 29 | 2022 |
| Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (alliance) R Bueno, WG Richards, DH Harpole, KV Ballman, MS Tsao, Z Chen, ... Journal of Thoracic Oncology 15 (11), 1748-1757, 2020 | 26 | 2020 |
| Endometriosis: benign, malignant, or something in between? MH Chui, TL Wang, IM Shih Oncotarget 8 (45), 78263, 2017 | 25 | 2017 |
| Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma MH Chui, Y Wang, RC Wu, J Seidman, RJ Kurman, TL Wang, IM Shih Modern Pathology 28 (3), 437-445, 2015 | 24 | 2015 |
| Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma MH Chui, AM Boroujeni, D Mandelker, M Ladanyi, RA Soslow Modern Pathology 34 (2), 490-501, 2021 | 20 | 2021 |
| Oncogenic BRAF and KRAS mutations in endosalpingiosis MH Chui, IM Shih The Journal of pathology 250 (2), 148-158, 2020 | 17 | 2020 |
